262 related articles for article (PubMed ID: 29374026)
1. A broad atlas of somatic hypermutation allows prediction of activation-induced deaminase targets.
Álvarez-Prado ÁF; Pérez-Durán P; Pérez-García A; Benguria A; Torroja C; de Yébenes VG; Ramiro AR
J Exp Med; 2018 Mar; 215(3):761-771. PubMed ID: 29374026
[TBL] [Abstract][Full Text] [Related]
2. Activation-induced deaminase: light and dark sides.
de Yébenes VG; Ramiro AR
Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
[TBL] [Abstract][Full Text] [Related]
3. Mutating for Good: DNA Damage Responses During Somatic Hypermutation.
Pilzecker B; Jacobs H
Front Immunol; 2019; 10():438. PubMed ID: 30915081
[TBL] [Abstract][Full Text] [Related]
4. Expression of human AID in yeast induces mutations in context similar to the context of somatic hypermutation at G-C pairs in immunoglobulin genes.
Mayorov VI; Rogozin IB; Adkison LR; Frahm C; Kunkel TA; Pavlov YI
BMC Immunol; 2005 Jun; 6():10. PubMed ID: 15949042
[TBL] [Abstract][Full Text] [Related]
5. Strand-biased spreading of mutations during somatic hypermutation.
Unniraman S; Schatz DG
Science; 2007 Aug; 317(5842):1227-30. PubMed ID: 17761884
[TBL] [Abstract][Full Text] [Related]
6. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
[TBL] [Abstract][Full Text] [Related]
7. Integrity of immunoglobulin variable regions is supported by GANP during AID-induced somatic hypermutation in germinal center B cells.
Eid MMA; Shimoda M; Singh SK; Almofty SA; Pham P; Goodman MF; Maeda K; Sakaguchi N
Int Immunol; 2017 May; 29(5):211-220. PubMed ID: 28541550
[TBL] [Abstract][Full Text] [Related]
8. The Complex Interplay between DNA Injury and Repair in Enzymatically Induced Mutagenesis and DNA Damage in B Lymphocytes.
Bahjat M; Guikema JEJ
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867784
[TBL] [Abstract][Full Text] [Related]
9. The role of activation-induced cytidine deaminase in lymphomagenesis.
Gu X; Shivarov V; Strout MP
Curr Opin Hematol; 2012 Jul; 19(4):292-8. PubMed ID: 22517589
[TBL] [Abstract][Full Text] [Related]
10. Restriction of AID activity and somatic hypermutation by PARP-1.
Tepper S; Mortusewicz O; Członka E; Bello A; Schmidt A; Jeschke J; Fischbach A; Pfeil I; Petersen-Mahrt SK; Mangerich A; Helleday T; Leonhardt H; Jungnickel B
Nucleic Acids Res; 2019 Aug; 47(14):7418-7429. PubMed ID: 31127309
[TBL] [Abstract][Full Text] [Related]
11. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation.
Pham P; Bransteitter R; Petruska J; Goodman MF
Nature; 2003 Jul; 424(6944):103-7. PubMed ID: 12819663
[TBL] [Abstract][Full Text] [Related]
12. Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias.
Xiao Z; Ray M; Jiang C; Clark AB; Rogozin IB; Diaz M
Mol Immunol; 2007 Apr; 44(10):2659-66. PubMed ID: 17240451
[TBL] [Abstract][Full Text] [Related]
13. Somatic hypermutation: processivity of the cytosine deaminase AID and error-free repair of the resulting uracils.
Storb U; Shen HM; Nicolae D
Cell Cycle; 2009 Oct; 8(19):3097-101. PubMed ID: 19738437
[No Abstract] [Full Text] [Related]
14. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation.
Basu U; Chaudhuri J; Alpert C; Dutt S; Ranganath S; Li G; Schrum JP; Manis JP; Alt FW
Nature; 2005 Nov; 438(7067):508-11. PubMed ID: 16251902
[TBL] [Abstract][Full Text] [Related]
15. Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases.
Zanotti KJ; Gearhart PJ
DNA Repair (Amst); 2016 Feb; 38():110-116. PubMed ID: 26719140
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
Pérez-Durán P; de Yebenes VG; Ramiro AR
Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
[TBL] [Abstract][Full Text] [Related]
17. The BRCT domain of PARP-1 is required for immunoglobulin gene conversion.
Paddock MN; Buelow BD; Takeda S; Scharenberg AM
PLoS Biol; 2010 Jul; 8(7):e1000428. PubMed ID: 20652015
[TBL] [Abstract][Full Text] [Related]
18. Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.
Ouadani H; Ben-Mustapha I; Ben-Ali M; Larguèche B; Jovanic T; Garcia S; Arcangioli B; Elloumi-Zghal H; Fathallah D; Hachicha M; Masmoudi H; Rougeon F; Barbouche MR
Mol Immunol; 2016 Nov; 79():77-82. PubMed ID: 27716525
[TBL] [Abstract][Full Text] [Related]
19. AID targeting in antibody diversity.
Pavri R; Nussenzweig MC
Adv Immunol; 2011; 110():1-26. PubMed ID: 21762814
[TBL] [Abstract][Full Text] [Related]
20. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
Durandy A; Peron S; Taubenheim N; Fischer A
Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
